Nickan Research Institute Journal of Renal Injury Prevention 2345-2781 14 3 2025 09 01 Serum magnesium level in peritoneal dialysis patients e34301 e34301 10.34172/jrip.2024.34301 EN Sahar Ravanshad https://orcid.org/0000-0003-1421-5339 Mohammad Mohammadian https://orcid.org/0009-0007-0254-2021 Mohammadhossein Taherynejad https://orcid.org/0000-0001-9583-1357 Zahra Lotfi https://orcid.org/0000-0002-9560-5955 Maryam Emadzadeh https://orcid.org/0000-0002-1526-3765 Maryam Miri https://orcid.org/0000-0002-9962-6753 Journal Article 10.34172/jrip.2024.34301 2024 01 16 2024 03 15 Introduction: Electrolyte imbalances are common among dialysis patients, and disorders related to magnesium, calcium, and phosphorus are particularly concerning. However, comparatively less research is available on disorders related to magnesium ion disorders. Objectives: This paper aims to assess magnesium disorders in patients with renal failure undergoing peritoneal dialysis. Patients and Methods: In this cross-sectional study, we recruited patients who had been undergoing peritoneal dialysis for at least three months. We collected demographic information, body mass index (BMI), drug history, the underlying disease leading to renal failure, duration of dialysis, and serum magnesium level. Additionally, we measured levels of calcium, phosphorus, parathyroid hormone (PTH), albumin, and 25-hydroxyvitamin D. Results: A total of 91 patients were undergoing peritoneal dialysis, including 41.8% women and 58.2% men, with a mean magnesium level of 2.86±0.53 mg/dL. More than 70% of patients had hypermagnesemia and only one patient suffered from hypomagnesemia. Diabetic patients had a lower magnesium level than non-diabetics (P=0.01). Conclusion: Given the frequent occurrence of electrolyte imbalance in peritoneal dialysis, it may be necessary to regularly monitor electrolyte levels and make appropriate adjustments to both the patient’s diet and electrolyte levels.